Is Biocon on the track to recovery?

Is Biocon on the track to recovery?

A leading biopharmaceutical powerhouse, renowned for pioneering innovative drug development and biologics, is showing promising signs of market recovery. Recent financial moves include a strategic equity acquisition in its biologics division and an impressive 200%...
×